- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04827914
Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1
January 3, 2024 updated by: Kenneth M Cummings, PhD, Medical University of South Carolina
Dissemination of an Inpatient Smoking Cessation Program to South Carolina Hospitals Study #1
The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion).
The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1122
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- MUSC
-
Charleston, South Carolina, United States, 29425
- Institute of Psychiatry
-
Chester, South Carolina, United States, 29706
- MUSC
-
Florence, South Carolina, United States, 29505
- MUSC
-
Lancaster, South Carolina, United States, 29720
- MUSC
-
Marion, South Carolina, United States, 29574
- MUSC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18+ years and older
- hospitalized cigarette smokers eligible for either enhanced or basic care
- discharged from the hospital back to their home
Exclusion Criteria:
- patients without a phone number
- those unable to communicate in the English language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Enhanced Care Condition
|
Smokers in the enhanced care group will receive live counseling (either in person or telehealth consult) while hospitalized combined with post-hospital discharge automated calls using interactive voice recognition (IVR) technology.
|
Active Comparator: Basic Care Condition
|
Smokers assigned to the basic care group will only receive the post-discharge IVR phone calls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported smoking prevalence 6-weeks after hospitalization.
Time Frame: Assessed 6-weeks post-discharge
|
Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)
|
Assessed 6-weeks post-discharge
|
Self-reported use of FDA Approved Smoking Cessation Medication
Time Frame: Assessed 6-weeks post-discharge
|
Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2.5-fold greater use of an FDA approved stop smoking medication after hospitalization (i.e., 20% vs 8%)
|
Assessed 6-weeks post-discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kenneth M Cummings, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 8, 2021
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 1, 2025
Study Registration Dates
First Submitted
March 30, 2021
First Submitted That Met QC Criteria
March 30, 2021
First Posted (Actual)
April 1, 2021
Study Record Updates
Last Update Posted (Actual)
January 5, 2024
Last Update Submitted That Met QC Criteria
January 3, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 107000
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States
Clinical Trials on Enhanced Care
-
The Miriam HospitalNational Institute on Aging (NIA)Recruiting
-
Massachusetts General HospitalActive, not recruiting
-
Baylor College of MedicineM.D. Anderson Cancer Center; Harris County Hospital District; Texas A&M University and other collaboratorsCompleted
-
Wake Forest University Health SciencesPatient-Centered Outcomes Research InstituteNot yet recruitingChildren With Medical ComplexityUnited States
-
Kwong Wah HospitalCompletedHypertension | Blood PressureHong Kong
-
VA Office of Research and DevelopmentUniversity of Wisconsin, MadisonActive, not recruitingTobacco Dependence | VeteransUnited States
-
Seattle Children's HospitalNational Institute of Mental Health (NIMH); University of Washington; Kaiser...Completed
-
Virginia Commonwealth UniversityAgency for Healthcare Research and Quality (AHRQ)RecruitingMental Health | Health Behavior | Multiple Chronic Conditions | Social Determinants of HealthUnited States
-
US Department of Veterans AffairsCompletedGeriatrics | Drug Therapy | Poly PharmacyUnited States